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GATA-1 Converts Lymphoid and Myelomonocytic
Progenitors into the Megakaryocyte/Erythrocyte
Lineages
2000; Kondo et al., 1997), granulocyte/monocyte (GM)
versus megakaryocyte/erythroid (MegE) (Akashi et al.,
2000), and B versus T lymphoid commitment (Allman
et al., 2002). Once lineage choices are made at each
branchpoint, progenitors display increasingly limited lin-
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points, including myeloid versus lymphoid (Akashi et al., but not GATA-1, is also highly expressed in HSCs (Na-
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ruption of the murine GATA-1 gene caused fatal embry- tiation pathway such as CMPs and megakaryocyte/ery-
throid progenitors (MEPs) (Akashi et al., 2000). Inonic anemia due to a block in erythroid maturation (Fuji-
wara et al., 1996). This phenotype could be explained contrast, GATA-2 is expressed in HSCs and MEPs at a
high level and in CMPs at a low level. FOG-1, a complexby the loss of the erythroid survival-promoting activity
of GATA-1 (Weiss and Orkin, 1995). Both GATA-2 and nine zinc-finger protein, interacts with GATA-1 and
GATA-2 (Tsang et al., 1997), and is essential for earlyGATA-3 could rescue the GATA-1-deficient phenotype
to a certain degree (Takahashi et al., 2000; Tsai et al., MegE development (Tsang et al., 1998). FOG-1 is ex-
pressed along the MegE differentiation pathway, and its1998), suggesting a functional redundancy among these
factors in MegE development. The instructive effect of distribution resembles that of GATA-1. GATA-1, GATA-2,
and FOG-1 are not expressed in GMPs or in lymphoidGATA-1 on MegE and eosinophil commitment has been
elegantly demonstrated in a multipotential chicken cell progenitors including CLPs, proT, and proB cells.
Figure 1C illustrates the retroviral construction usedline transformed by the Myb-Ets-encoding E26 leukemia
virus. These cells became immature GM progenitors by in this study, and Figure 1D shows the result of GATA-1
transduction into purified HSCs by using the retrovirusenforced expression of PU.1 but could regain erythroid
or eosinophilic potentials by enforced expression of vector carrying a green fluorescent protein (GFP) re-
porter. After 2 day coculture with control retrovirus su-GATA-1 (Kulessa et al., 1995). Introduction of GATA-1
into myeloid cell lines induces megakaryocyte differenti- pernatants, approximately 40% of HSCs expressed
GFP. GATA-1 transduction, as measured by GFP fromation (Visvader et al., 1992) with upregulation of MegE-
affiliated genes such as the erythropoietin receptor a downstream IRES element, was seen at similar levels
of approximately 35%. We purified GFPlo cells after(EpoR) and -globin (Seshasayee et al., 1998; Yama-
guchi et al., 1998). Furthermore, GM-restricted colony- transduction for all experiments, since GFPlo HSCs (Fig-
ure 1E) or GMPs (not shown) expressed GATA-1 at levelsforming cells, which are selectively generated in culture,
can give rise to erythroblasts and eosinophils upon ec- comparable to endogenous GATA-1 expression in puri-
fied MEPs.topic GATA-1 induction (Heyworth et al., 2002). These
studies suggest that GATA-1 is sufficient to reactivate
the MegE and/or eosinophil differentiation programs in Enforced GATA-1 Expression in Hematopoietic Stem
immature myelomonocytic cells. Cells and Common Myeloid Progenitors Instructs
In most of these previous studies, culture-adapted Megakaryocyte/Erythroid Lineage Commitment
cell lines were used, and/or the hematopoietic stage of We first tested the effect of enforced GATA-1 in HSCs
target cells was unclear. It should also be noted that and CMPs. GATA-1 was introduced into highly purified
interaction with other transcription factors (i.e, C/EBP HSCs with long-term reconstitution activity (Lineage
for eosinophil development [McNagny et al., 1998; Ner- [Lin]–CD34/loSca-1c-Kit HSCs) (Okuno et al., 2002;
lov et al., 1998] and FOG-1 for megakaryocyte develop- Osawa et al., 1996) and CMPs. HSCs introduced with
ment [Chang et al., 2002]) might be required for GATA-1 control vector gave rise to a variety of myelo-erythroid
to exert its effects on target cells. Each progenitor popu- colonies (Figures 2A and 2B), as did freshly isolated
lation in turn likely possesses stage-specific chromatin HSCs (Akashi et al., 2000). Strikingly, GATA-1 HSCs
accessibility (Akashi et al., 2003) to dictate expression gave rise only to MegE-affiliated colonies at over 80%
of specific gene sets. These concerns led us to directly plating efficiency in methylcellulose. Enforced expres-
evaluate the biological effects of enforced GATA expres- sion of GATA-1 in CMPs also resulted in the exclusive
sion in lineage-restricted progenitor subsets. formation of MegE-affiliated colonies. Interestingly,
Using purified stem and progenitor cells including GATA-1-induced MegE colony formation from HSCs and
HSCs, CMPs, CLPs, and granulocyte/monocyte progen- CMPs was seen irrespective of the presence of erythro-
itors (GMPs) (Akashi et al., 2000), we show here that poietin (Epo) or thrombopoietin (Tpo). Eosinophil pro-
enforced expression of GATA-1 instructs each subset to duction was not detected under these culture condi-
generate megakaryocytes and erythrocytes. Strikingly, tions.
GATA-1 converted CLPs into the MegE lineages, blocking We then tested the in vivo differentiation activity of
normal lymphoid differentiation. GATA-1 also converted GATA-1 HSCs. Two hundred GATA-1 HSCs (C57B6-
GMPs into the MegE and eosinophil lineages and inhib- Ly5.2) were transplanted with 2  105 host-type (Ly5.1)
ited normal differentiation into neutrophils and mono- bone marrow cells to competitively reconstitute lethally
cytes. Taken together, GATA-1 both specifies MegE com- irradiated congenic hosts (C57B6-Ly5.1). The pheno-
mitment and simultaneously prevents GM and lymphoid type of donor-derived cells (GFPLy5.2) was evaluated
development. by multicolor FACS analyses at different time points.
HSCs introduced with the control GFP construct recon-
stituted all lymphoid and myeloid lineages (Figure 2C),Results
and multilineage donor-derived hematopoiesis was
maintained for over 4 months (not shown), indicatingEndogenous and Enforced Expression of GATA-1
in Hematopoietic Cell Subsets the successful introduction of GFP-tagged retroviruses
into long-term HSCs. In contrast, GATA-1 HSCs gaveFigure 1A depicts the hematopoietic developmental tree
and the progenitors used in this study. Semiquantitative rise only to Ter119 erythroid cells, but not Gr-1 GM
cells, CD3 T cells, or B220 B cells (Figure 2C). TheRT-PCR analyses were performed to evaluate the distri-
bution of GATA-1, GATA-2, and FOG-1 (Figure 1B). erythroid progeny of GATA-1 HSCs disappeared within
3 weeks. These data indicate that enforced expressionGATA-1 is expressed at a low level in HSCs and is gradu-
ally upregulated in progenitors along the MegE differen- of GATA-1 directs MegE commitment at the level of
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Figure 1. The Expression and Transduction of GATA-1 in Hematopoietic Stem and Progenitor Cells
(A) Lineage relationships of prospectively isolatable lineage-restricted progenitors in murine hematopoiesis.
(B) Results of RT-PCR analyses of GATA-1, GATA-2, and FOG-1 using 250 cells per progenitor species. The symbols under each lane depict
relative amounts of mRNA in each population compared to control cDNA (2  105 whole BM cells—bands not shown) by the Pixel Density
Units ratio: 0.1 (-), 0.1–0.5 (), 0.5–1.5 (), 1.5 ().
(C) Retroviral construct used in this study.
(D) GFP expression in HSCs infected with control- and GATA-1-GFP viruses for 48 hr.
(E) The expression level of GATA-1 in transduced HSCs. PCR analyses of 1,000 sorted GFPlo cells and MEPs using graded dilutions of cDNA
showed that GFPlo cells expressed amounts of GATA-1 mRNA comparable to endogenous MEP levels.
HSCs and CMPs at the expense of GM and/or lymphoid nies at 40%–50% plating efficiency, irrespective of the
presence of myelo-erythroid cytokines (Figure 3A).differentiation.
GATA-1 CLP-derived colonies were comprised of a
majority of small, benzidine cells (Iuchi and Yamamoto,
Ectopic GATA-1 Expression in CLPs Induces 1983), and a minority of scattered large multi-nucleate
Megakaryocyte/Erythroid Lineage Conversion cells expressing P-selectin (CD62P), known to be ex-
Instruction to the MegE lineages in GATA-1 HSCs and pressed on activated platelets, megakaryocytes, and
CMPs suggests that the upregulation of GATA-1 to lev- endothelial cells (Johnston et al., 1989) (Figure 3B). Thus,
els physiologically observed in MEPs might be required the cells within GATA-1 CLP-derived colonies were
for cells to commit to the MegE lineages. In turn, this hemoglobinized erythroblasts and mature megakaryo-
suggests that the downregulation of GATA-1 may be cytes, respectively. The size and cell component of
critical for multipotent progenitors to lose MegE poten- GATA-1 CLP-derived MegE colonies were comparable
tials during the transition from HSC to CLP stages. To to those from freshly isolated MEPs (Figure 3B).
test this hypothesis, we enforced GATA-1 expression in By competitive reconstitution assays, control GFP
CLPs. CLPs differentiated into CD3 T cells, B220 B cells
As shown in Figure 3A, 86% of control GFP CLPs (Figure 3C), and CD3–B220–NK1.1 NK cells (not shown)
gave rise to B cell colonies. Colonies of myelo-erythroid on day 14, but not into Ter119 or Gr-1 myelo-erythroid
cells were not seen in these cultures even in the pres- cells, representing normal physiological differentiation
ence of Epo and Tpo, cytokines fully permissive for activity (Kondo et al., 1997). Lymphoid progeny from
control GFP CLPs were found in the bone marrow, thenormal MegE readouts. GATA-1CLPs gave rise to colo-
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Figure 2. Lineage Potentials of GATA-1-Transduced HSCs and CMPs
(A) Differential counts of colonies from HSCs and CMPs introduced with GATA-1 or control GFP constructs.
(B) Colonies derived from control GFP HSCs (upper left) and GATA-1 HSCs (upper right) observed under an inverted microscope. Morphology
of cells from a control GFP HSC-derived mixed colony (bottom left) and from a GATA-1 HSC-derived MegE colony (bottom right) are shown
(May-Giemsa staining 1,000). (C) In vivo differentiation of control GFP or GATA-1 HSCs (Ly5.2) in the spleen on day 14. Donor-derived
cells were evaluated by the expression of Ly5.2 and GFP in FITC channel.
thymus, and the spleen. In contrast, GATA-1CLPs gave uous evaluation of single GATA-1 proB cells revealed
rise only to Ter119 erythroid cells on day 14 in the that they underwent only 1 or 2 cell divisions by day 3,
spleen and bone marrow, which disappeared by day 21 and rapidly disappeared from the cultures on day 4 (not
(Figure 3C), whereas lymphoid or GM-related progeny shown). To test the possibility that ectopic GATA-1 ex-
were undetectable in the spleen, bone marrow, blood, pression leads to cell death, we evaluated whether over-
or thymus by multiple evaluations from 14 to 90 days expression of the antiapoptotic Bcl-2 protein could res-
after transplantation (Figure 3C and not shown). These cue differentiation of GATA-1 proB cells. ProB cells
data strongly suggest that GATA-1 can convert CLPs purified from mice ubiquitously expressing human Bcl-2
into the MegE lineages at the expense of their physiolog- (Domen et al., 1998) were used. However, the reinforce-
ical lymphoid potentials. ment of proB cell survival by Bcl-2 did not affect the
inhibitory action of GATA-1 on B cell differentiation (Fig-
ure 4A, right), nor did it maintain cell growth (Figure 4B).Ectopic GATA-1 Expression Suppresses Proliferation
We then evaluated reactivity of cultured Bcl-2 transgenicand Survival of B Cell-Committed Progenitors
(Tg) proB cells with Annexin V, which specifically bindsWe directly evaluated the inhibitory effect of GATA-1 on
to translocated phosphatidylserine molecules on theproB cell differentiation in vitro. B220CD43IgM– proB
surface of apoptotic cells (Vermes et al., 1995). As showncells were purified, transduced with GATA-1, and cul-
in Figure 4C, the majority of Bcl-2 Tg proB cells becometured on S17 stromal cell layers with IL-7. One in six
Annexin V 3 days after the GATA-1 transduction. Thus,control GFP proB cells differentiated into mature
ectopic GATA-1 inhibits proB cell differentiation at leastCD19IgM B cells under these culture conditions (Fig-
by inducing apoptotic cell death, which cannot be res-ure 4A, left). In contrast, B cell progeny could not be
found in cultures of1,000 GATA-1 proB cells. Contin- cued by Bcl-2.
Hematopoietic Lineage Conversion by GATA-1
455
Figure 3. Enforced GATA-1 Converts CLPs into the MegE Lineages
(A) Differential counts of colonies derived from control GFP or GATA-1 CLPs.
(B) Morphology of cells from a control GFP CLP-derived preB colony (a) and from a GATA-1 CLP-derived MegE colony (b) are shown (May-
Giemsa staining, 1,000). Small cells in GATA1 CLP-derived colonies were benzidine positive (c) and large cells were CD62P positive (d:
green, GFP; red, CD62P). MegE colonies derived from normal MEPs (e) and from GATA-1 CLPs (f) (100).
(C) In vivo differentiation of control GFP or GATA-1 CLPs evaluated in the spleen on day 14. GATA-1 CLPs differentiated only into Ter119
erythroid cells.
Ectopic GATA-1 Expression in GMPs Induces of GATA-1 GMPs consisted mainly of erythroblasts,
megakaryocytes, and eosinophils, but not neutrophilsMegakaryocyte/Erythroid Lineage Conversion
Another important hematopoietic fate decision related or monocytes. Approximately 40% of single GATA-1
GMPs gave rise to erythroid cells reacting with benzidineto GATA-1 regulation is the GM versus MegE branch-
point (Figure 1A). We enforced GATA-1 expression in staining (not shown), but their proliferation was limited
and they did not form colonies containing more thanGMPs to examine changes in their fate potential. In the
liquid culture containing Slf, IL-3, GM-CSF, Epo, and 20 cells. Similar to the GATA-1 HSCs and CLPs, the
development of MegE cells from GATA-1 GMPs wasTpo, control GFPGMPs actively proliferated and exclu-
sively gave rise to Gr-1 GM cells such as neutrophils, unchanged even in the absence of Epo and Tpo (not
shown). Thus, enforced expression of GATA-1 convertsmonocytes, macrophages, and rare eosinophils (Figure
5A), corresponding to their physiological lineage poten- GMPs into the MegE and eosinophil lineages, sup-
pressing GM differentiation.tials (Akashi et al., 2000). In contrast, a vast majority of
GATA-1 GMPs did not display significant proliferation
(Figure 5B). Strikingly, day 5 GATA-1 GMP progeny in- Bcl-2 or GM-CSF Signals Cannot Rescue
the GATA-1-Induced Apoptotic Cell Deathcluded Ter119 erythroid cells and Gr-1lo eosinophils (Fig-
ure 5A). Ter119–Gr-1– cells purified from GATA-1 GMP in Granulocyte/Monocyte-Committed Cells
As shown in Figure 5B, control GFP GMPs continuedcultures were composed of megakaryocytes and rela-
tively mature erythroblasts that have lost Ter119 expres- to proliferate until day 6, giving rise exclusively to GM
cells. In contrast, all single GATA-1 GMPs divided onlysion (not shown). As shown in Table 1, the day 5 progeny
Immunity
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Figure 4. GATA-1 Suppresses the Differentiation of ProB Cells
(A) Limiting dilution analysis of B cell potential of control GFP or GATA-1 proB cells on an S17 stromal layer. One in six control GFP proB
cells differentiated into CD19IgM B cells, whereas GATA-1 proB cells did not (left). GATA-1-induced inhibition of B cell differentiation was
also seen in Bcl-2 transgenic proB cells (right).
(B) Sequential evaluation of numbers of nucleated cells derived from single control GFP (black lines) or GATA-1 proB cells (red lines).
(C) Annexin V staining of GATA-1 or control GFP proB cells 3 days after the retroviral transduction. Dead cells are excluded by positive
staining for propidium iodide (PI).
2 to 4 times by day 3, and a majority of their progeny GMP cultures, neutrophil development was rarely found
in GATA-1 Bcl-2 Tg GMP cultures, and the progenyprogressively disappeared in the cultures by day 5, pre-
sumably by apoptotic cell death. After day 5, erythro- was mainly composed of MegE cells and eosinophils
(Table 1). Percentages and the cell type of AnnexinVblasts rapidly become small erythrocytes by denuclea-
tion, whose numbers were not included in Figure 5B. cells on day 3 were not affected by the presence of
Bcl-2 (Figure 5C).We performed the AnnexinV analysis from day 3 cul-
tures, when the number of GATA-1 GMP progeny We next enforced transgenic hGM-CSFR expression
in GATA-1 GMPs. Forced hGM-CSF signals can pro-reached its peak (Figure 5B). As shown in Figure 5C,
day 3 progeny of control GFP GMPs did not contain a vide growth-stimulating and antiapoptotic “permissive”
signals for myelo-erythroid development (Iwasaki-Araisignificant AnnexinV population. In contrast, 20% of
day 3 progeny of GATA-1 GMPs were AnnexinV and et al., 2003; Liu et al., 2000). GMPs were purified from
the H-2Ld-hGM-CSFR/	c double transgenic mice inundergoing apoptotic cell death (Figure 5D). Propidium
iodide (PI)–AnnexinV cells at an early phase of apopto- which transgenic hGM-CSFR was ubiquitously ex-
pressed (Nishijima et al., 1995). GATA-1 hGM-CSFR Tgsis were mainly morphologically immature myeloid cells
with azulophilic granules (Figure 5D), and expressed GMPs again ceased cell division by day 3 irrespective of
the presence of hGM-CSF (Figure 5B), and their progeny“myeloid” Fc
RII/III at a high level (not shown). In con-
trast, both Gr-1lo eosinophil and Ter119 erythroid prog- composed mainly of MegE cells and eosinophils (Table
1). Thus, enforced permissive Bcl-2 and hGM-CSF sig-eny in day 3 GATA-1 GMP cultures were AnnexinV.
We then tested the effect of Bcl-2 on the apoptotic nals failed to restore the neutrophil/monocyte potentials
of GATA-1 GMPs.cell death of GATA-1-expressing GM cells. GMPs were
purified from H-2k-Bcl-2 Tg mice. Similar to GATA-1
wild-type GMPs, single GATA-1 Bcl-2 Tg GMPs prolif- Megakaryocyte/Erythroid-Related Genes Including
FOG-1 and GATA-2 Are Upregulated upon GATA-1erated up to 20 cells by day 3, when cells ceased
cell division. The progeny of GATA-1 Bcl-2 Tg GMPs Transduction into CLPs and GMPs
We evaluated expression changes of lineage-affiliatedsurvived until day 5 (Figure 5B), but gradually disappeared
during the culture. On day 5, similar to GATA-1 wild-type genes after GATA-1 or control GFP transduction into
Hematopoietic Lineage Conversion by GATA-1
457
Figure 5. GATA-1 Converts GMPs into the MegE Lineages
(A)Analysis of cell types from liquid cultures of 500 control GFP or GATA-1 GMPs. Control GFP GMPs differentiated exclusively into
neutrophils (N), monocytes/macrophages (M), and scattered eosinophils (Eo), whereas GATA-1 GMPs differentiated into erythroblasts (Ery),
megakaryocytes (Meg), and eosinophils (Eo).
(B) Sequential evaluation of numbers of nucleated cells derived from single control GFP (black lines, left panel) or GATA-1 GMPs (red lines,
left panel). Note that GATA-1 GMPs proliferated until day 3 but gradually disappeared from the culture thereafter. GATA-1 Bcl-2 Tg GMPs
displayed similar proliferative responses (red lines, middle panel), although their numbers were maintained until day 4. GATA-1 hGM-CSFR
Tg GMPs displayed impaired proliferation similar to GATA-1 wild-type GMPs, irrespective of the presence (blue lines, right panel) or absence
(red lines, right panel) of hGM-CSF.
(C) Annexin V analyses of GATA-1 GMPs 3 days after retrovirus infection. Dead cells were excluded by positive staining for PI in this analysis.
Control GFP GMPs did not contain cells that reacted with Annexin V (left). Day 3 progeny of GATA-1 GMPs contained 20% Annexin V
cells (middle). Although a small fraction of Annexin V cells expressed Gr-1 (upper middle), all Ter119 cells were negative for Annexin V
(lower middle). The percentage of Annexin V cells was unchanged by transgenic Bcl-2 expression (right). (D) Morphology of purified cells in
day 3 cultures of GATA-1 GMPs. PIAnnexin V dead cells characterized by condensed and fragmented nuclei (a) and PI–Annexin V cells
in the process of apoptosis (b) are shown.
CLPs and GMPs. mRNA was extracted from each subset as G-CSFR, M-CSFR, and GM-CSFR, but upregulated
the MegE-affiliated EpoR and 	-globin (Figure 6B). Thus,immediately after the completion of retroviral infection.
After the transduction of GATA-1, CLPs upregulated expression profiles of GMPs and CLPs after GATA-1
transduction resemble those of freshly isolated MEPsMegE-related genes such as EpoR, 	-globin, and GPIIb,
whereas they downregulated lymphoid genes such as (Figure 6C). Compatible with in vitro data, the upregula-
tion of eosinophil peroxidase (EoPO) was observed inIL-7R, Notch-1 (Robey, 1999), GATA-3, Pax-5, and EBF
(Lin and Grosschedl, 1995) (Figure 6A). GATA-1 GMPs GATA-1 GMPs, but not in GATA-1 CLPs. The expres-
sion of PU.1 and C/EBP was unchanged by GATA-1downregulated GM-affiliated cytokine receptors such
Table 1. Differential Counts of GATA-1 GMP Cultures
Percentage of Cell Types
Mouse Transduction Neutrophil Eosinophil Monocyte Erythroid Megakaryocyte
WT Control 81.2 0.4 18.4 0 0
GATA-1 1.0 18.2 0 66.4 14.4
Bcl2 Tg Control 82.2 0.6 17.2 0 0
GATA-1 1.8 18.6 0 63.6 16.0
hGM-CSFR Tg Control 60.4 0.4 39.2 0 0
GATA-1 0.4 38.6 0 48.6 12.4
Five hundred control/GFP and GATA-1/GFP GMPs were cultured in medium supplemented with Slf, IL-3, mGM-CSF, Epo, and Tpo,
respectively. hGM-CSF was added in the case of hGM-CSFR Tg GMP cultures. After 4 days of culture, cytospin preparations were stained
with May-Giemsa and differentially counted.
Immunity
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Figure 6. Changes in the Expression of Lineage-Affiliated Genes by Ectopic GATA-1 or FOG-1 Expression
(A and B) Changes in gene expression profiles after retroviral transduction with GATA-1 or control GFP constructs in CLPs and GMPs.
(C) Similar analyses using freshly isolated GMPs and MEPs.
(D) Colony-forming activity of HSCs and GMPs with enforced expression of FOG-1.
(E) Changes in gene expression profiles of GMPs after the retroviral transduction of FOG-1.
transduction in GMPs. Importantly, although CLPs and tial beyond their normal physiological limits by ectopic
signals. We showed here that GATA-1 specifically in-GMPs did not express GATA-2 or FOG-1, an essential
transcription factor for GATA-1 functions, both of these structs lymphoid and myelomonocytic progenitor sub-
sets to activate “silenced” MegE programs that theytranscription factors were upregulated after GATA-1 trans-
duction (Figures 6A and 6B). normally do not possess.
In addition to the MegE lineage instructive effect,
GATA-1 exerted a suppressive effect on GM andFOG-1 Does Not Instruct Megakaryocyte/Erythroid
lymphoid differentiation at least through inducing rapidLineage Development
apoptotic cell death. The enforced expression of PU.1,We then transduced FOG-1 into HSCs and GMPs to test
a transcription factor expressed in B and myeloid cellswhether enforced FOG-1 can instruct MegE develop-
(Klemsz et al., 1990), can similarly suppress T cell devel-ment as GATA-1 does. As shown in Figure 6D, enforced
opment at the level of proT cells (Anderson et al., 2002).expression of FOG-1 did not increase the number of
Panhematopoietic expression of another B cell-relatedMegE colonies in HSCs. FOG-1 GMPs actively prolifer-
transcription factor, Pax-5 (Nutt et al., 1997), promotesated and only formed GM colonies. These GM colonies
B cell development, whereas this treatment inhibitswere composed of neutrophils and monocytes, but did
T cell but not myeloid development (Souabni et al.,not contain a significant number of eosinophils. En-
2002). These data collectively suggest that the mecha-forced expression of FOG-1 did not upregulate GATA-1
nism of “lineage instruction” by transcription factorsor GATA-2 in GMPs (Figure 6E). Thus, in contrast to
should also include “lineage exclusion,” where the sup-GATA-1, FOG-1 does not instruct MegE lineage commit-
pression of specific differentiation programs may be asment or conversion, nor does it stimulate eosinophil
important as “lineage specification” (Rothenberg anddifferentiation from GMPs.
Dionne, 2002). Specific lineage exclusion by specific
transcription factors may be important to “stabilize” fateDiscussion
potentials upon commitment by alteration of chromatin,
for example. At oligopotent stages, priming of multipleThe role of signaling in lineage commitment can be di-
lineage-affiliated genes occurs prior to commitmentvided into at least two functional categories: permissive
(Akashi et al., 2003; Delassus et al., 1999; Hu et al.,and instructive. Permissive signals maintain active dif-
1997). In fact, single CMPs and CLPs coexpress myelo-ferentiation programs, while instructive signals activate
erythroid and T/B-specific lymphoid genes, respec-silenced programs. Since blood development occurs
tively, despite remaining uncommitted to downstreamthrough stem and progenitor cells that lose fate poten-
lineages (Miyamoto et al., 2002). The major myelo-ery-tials as they differentiate, significant evidence for lineage
instruction would be the conversion of progenitor poten- throid transcription factors including PU.1, C/EBP,
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GATA-1, and FOG-1 are primed at a low level in HSCs mitted to the GM lineage. Since the expression of
C/EBP is low in HSCs, highest in GMPs, and negativeand CMPs (Figure 1B). Thus, if lineage exclusion is a
common feature of transcription factors in controlling in CLPs (Akashi et al., 2000), our data is compatible with
a previous report in which the coexpression of GATA-1lineage decisions, upregulation of specific transcription
factors may be critical in both promoting selected lin- and C/EBP was required to induce eosinophils from a
multipotent chicken cell line (Nerlov et al., 1998). Thus,eage programs and suppressing unrelated programs.
Conversely, concomitant downregulation of irrelevant in terms of eosinophil development, GATA-1 may not
be upstream of C/EBP.transcription factors is likely equally important.
HSCs express only a small amount of GATA-1 mRNA. Our data on GATA-1 GMPs are generally consistent
with a recent report in which GATA-1 was expressedAt these levels, GATA-1 may not achieve a threshold
capable of exerting the lineage instruction we have ob- by tamoxifen-inducible estrogen-receptor (ER) fusion in
culture-selected GM progenitors (Heyworth et al., 2002).served with high-level expression within HSCs. Increas-
ing GATA-1 expression in HSCs to levels seen in normal In the ER-GATA-1 system, however, the majority of
“mixed” colonies derived from ER-GATA-1-induced GMMEPs resulted in the exclusive formation of colonies
containing MegE cells at 80% of plating efficiency. In progenitors contained erythroblasts, eosinophils, neu-
trophils, and monocytes, but not megakaryocytesdownstream CLP and GMP stages, enforced GATA-1
expression up to MEP levels induces MegE lineage con- (Heyworth et al., 2002), whereas in our system, both
erythroblasts and megakaryocytes were the major com-version. These data can be interpreted that CLPs and
GMPs are normally lymphoid and GM-restricted, re- ponents of the GATA-1 GMP progeny, and develop-
ment of neutrophil and monocyte was inhibited. Thesespectively, simply because they do not express GATA-1.
Furthermore, the MegE development by enforced ex- differences may be because hematopoietic stages of
cells targeted by retrovirus were different in these stud-pression of GATA-1 can occur in the absence of Epo or
Tpo. In our previous study (Akashi et al., 2000), CLPs ies. It is also possible that the level of GATA-1-induced
by the ER-GATA-1 system may be insufficient to pro-do not express EpoR or c-mpl, receptors for Tpo (Lok
et al., 1994), and enforced expression of EpoR in CLPs mote megakaryocyte development (Heyworth et al.,
2002) or to inhibit GM differentiation.does not induce MegE differentiation of CLPs (Kondo
et al., 2000). It was also shown that Epo signals are The inhibitory mechanism of lymphoid and GM devel-
opment induced by GATA-1 remains unclear. It has beennot required for the generation of erythroid-committed
progenitors (Wu et al., 1995). Thus, GATA-1 not only shown that GATA-1 inhibits binding of PU.1 to c-Jun, a
critical coactivator of PU.1 transactivation on myeloidinstructs the MegE fate decision but also maintains the
MegE differentiation of HSCs, CMPs, CLPs, and GMPs, promoters (Nerlov et al., 2000; Zhang et al., 1999, 2000).
Conversely, enforced PU.1 suppresses the expressionreplacing the permissive signals of these cytokines
(Weiss and Orkin, 1995; Wu et al., 1995). and DNA binding activity of GATA-1, resulting in a differ-
entiation block and apoptotic cell death of erythroid cellGATA-1 instruction of MegE conversion was associ-
ated with the reactivation of FOG-1 and GATA-2. FOG-1 lines (Nerlov and Graf, 1998; Yamada et al., 1998). PU.1
also regulates the expression of the IL-7 receptor (Scottis an essential transcription factor for MegE develop-
ment (Tsang et al., 1998), and GATA-1 or GATA-2 binding et al., 1997), whose principal role in T cell development
is to prevent apoptotic cell death at least through upreg-is a general requirement for FOG-1 function (Chang et
al., 2002). Enforced expression of FOG-1, however, did ulating Bcl-2 (Akashi et al., 1997). Thus, it is possible
that enforced GATA-1 expression may suppressnot affect the physiological myelo-erythroid fate of stem
and progenitor cells, nor did it upregulate GATA-1 or lymphoid and GM differentiation through blocking the
transcriptional activity of PU.1. However, enforced GM-GATA-2 (Figure 6). Furthermore, retrovirally transduced
GATA-2 GMPs displayed active proliferation giving CSF signals did not affect the differentiation of trans-
genic GMPs despite the fact that GM differentiation canrise exclusively to pure eosinophil colonies, whereas
GATA-2 CLPs produced normal numbers of B cells be rescued in PU.1/ progenitors with the provision of
myeloid growth factors including GM-CSF (Zhang et al.,(H.I. et al., unpublished data). Thus, neither FOG-1 or
GATA-2 instructs MegE conversion, nor does it exclude 1998). It is also important to note that the inhibitory
action of GATA-1 includes induction of apoptotic cellGM or lymphoid lineage differentiation potentials, al-
though GATA-2 is likely to be instructive for eosinophil death and inhibition of proliferation, both of which could
not be rescued by transgenic Bcl-2 or cytokine signals. Itdevelopment as reported (Hirasawa et al., 2002). These
data collectively suggest that GATA-1 is the master reg- is unclear whether enforced GATA-1 directly suppresses
the cell cycling machinery of proB cells and GMPs, orulator for MegE commitment that might act upstream of
FOG-1 and GATA-2, and that the reactivation of GATA-1 whether GATA-1 induces directly their apoptotic cell
death. The mechanisms of GATA-1-induced suppres-appears to be sufficient for and a minimum requirement
for MegE conversion. It is of interest to similarly test the sion of cell growth and survival should be elucidated in
future studies.function of GATA-3 in MegE and eosinophil develop-
ment at each hematopoietic stage because enforced Our study indicates that lineage commitment among
immature hematopoietic progenitors is not absolute.expression of GATA-3 in HSCs was shown to induce
their preferential differentiation into MegE cells (Chen Despite the fact that the branchpoint represented by
the CMP and CLP subsets normally generate mutuallyand Zhang, 2001).
The stimulation of eosinophil differentiation by en- exclusive progeny, ectopic GATA-1 expression is suffi-
cient to uncover latent MegE potential in CLPs that areforced GATA-1 was found within GMP cultures, but not
from plated HSCs or CLPs, suggesting that GATA-1 can normally lymphoid-restricted. CLPs also harbor signifi-
cant plasticity for GM differentiation evoked by ectopicpromote eosinophil differentiation once cells have com-
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ogies, Vancouver, Canada), supplemented with 30% fetal bovinecytokine signals (Iwasaki-Arai et al., 2003; Kondo et al.,
serum (FBS), 1% bovine serum albumin, 2 mM L-glutamine, and2000). Taken together, our data indicate that CLPs pos-
50 M 2-mercaptoethanol. In some experiments, single cells weresess the “hidden” multipotentiality to generate the major
sorted into Terasaki plates with IMDM containing 20% FBS. Cyto-
myelo-erythroid lineages. The proper regulation of tran- kines such as mSlf (20 ng/ml), mIL-3 (10 ng/ml), mIL-11 (10 ng/ml),
scription factor or cytokine receptor expression at each mGM-CSF (10 ng/ml), mTpo (10 ng/ml), hEpo (1 U/ml), and hGM-
CSF (20 ng/ml) were added at the start of the culture. Colonies werehematopoietic stage is thus critical to maintain the hier-
enumerated under an inverted microscope consecutively from dayarchical regulation of hematolymphoid development.
3 to day 8. Types of colonies were determined by Giemsa staining
of cells that were picked from individual colonies using fine-drawnExperimental Procedures
Pasteur pipettes. To define the MegE components, cells were
stained with acid benzidine (Iuchi and Yamamoto, 1983; SlaytonMice
et al., 2001) or biotinylated anti-CD62P (Pharmingen), followed byC57B6 (Ly5.1 or Ly5.2) mice, H-2k-Bcl-2 transgenic mice (Domen
avidin-PE (Caltag). To evaluate B cell differentiation potential, cellset al., 1998), and C57B6-H-2Ld-hGM-CSFR/	c double transgenic
were sorted onto irradiated (3,000 rad) S17 stromal layers in 96-wellmice (Nishijima et al., 1995) were used in this study. Mice were bred
plates in the presence of IL-7. All cultures were incubated at 37Cand maintained in the Research Animal Facility at the Dana-Farber
in a humidified chamber under 5% CO2.Cancer Institute in accordance with DFCI guidelines.
Sorting of Stem and Progenitor Cells
In Vivo Reconstitution Assays
Sorting of myeloid progenitors was accomplished by staining bone
Two hundred GFP HSCs or 7,000 GFP CLPs (Ly5.2) were intrave-
marrow cells with purified rat anti-IL-7R chain monoclonal antibod-
nously transplanted into congenic mice (Ly5.1) after a lethal dose
ies (A7R34) (e-Bioscience, San Diego, CA) and purified or PE-Cy5-
(950 rad) irradiation. 2  105 unfractionated BM cells (Ly5.1) were
conjugated rat antibodies specific for the following lineage markers:
cotransplanted to rescue these mice from lethal irradiation. Mice
CD3 (CT-CD3), CD4 (RM4-5), CD8 (5H10), B220 (6B2), Gr-1 (8C5),
were sacrificed on days 8, 14, 21, 28, and 120 to evaluate donor-
Ter119, and CD19 (6D5) (Caltag, Burlingame, CA). IL-7RLin cells
derived progeny by detecting both GFP and Ly5.2 in the FITC
were removed with sheep anti-rat IgG-conjugated magnetic beads
channel.
(Dynabeads M-450; Dynal A.S., Oslo, Norway), and the remaining
cells were stained with PE-Cy5-conjugated goat anti-rat IgG (Cal-
tag). Cells were then stained with PE-conjugated anti-Fc
RII/III Analysis of Apoptotic Cell Death
(2.4G2), FITC-conjugated anti-CD34 (RAM34), APC-conjugated anti- Cells undergoing apoptotic cell death were measured by Annexin
c-Kit (2B8), and biotinylated anti-Sca-1 (E13-161-7) monoclonal anti- V staining (Pharmingen) according to the manufacturer’s protocol.
bodies (Pharmingen, San Diego, CA), followed by avidin-APC-Cy7 In brief, 20,000 cells were stained with 5 l of APC-conjugated
(Caltag). Myeloid progenitors were sorted as IL-7RLinSca-1 Annexin V in 100 l of binding buffer. After 15 min incubation at
c-KitCD34Fc
RII/IIIlo (CMPs), IL-7RLin–Sca-1c-KitCD34Fc- room temperature, 400 l of binding buffer containing propidium

RII/IIIhi (GMPs), and as IL-7RLin–Sca-1c-KitCD34Fc
RII/IIIlo iodide (PI) (final concentration; 1 g/ml) was added, and cells were
(MEPs) as described previously (Akashi et al., 2000). HSCs and CLPs analyzed by FACS immediately. PIAnnexin V cells were defined
were sorted as IL-7RLinSca-1hic-Kithi and IL-7RLinSca-1lo as early apoptotic cells.
c-Kitlo populations, respectively (Kondo et al., 1997). In some experi-
ments, HSCs were further divided into CD34 long-term and CD34
short-term HSC populations (Okuno et al., 2002; Osawa et al., 1996). Analysis of Gene Expression from Total RNA
ProT and proB cells were sorted as CD3CD4CD8NK1.1c-Kit Total RNA was extracted from 2000 double-sorted cells for each
CD25CD44 and CD43B220IgM cells, respectively. Cells were population and reverse transcribed to cDNA as described previously
sorted using a highly modified double laser (488 nm/350 nm Enter- (Akashi et al., 2000). An aliquot of cDNA was analyzed for specific
prise II 647 nm Spectrum) high-speed FACS (Moflo-MLS, Cytoma- genes. Primer sequences and PCR protocols for each specific gene
tion, Fort Collins, CO). Data were analyzed with FlowJo software are shown in Supplemental Table S1 at http://www.immunity.com/
(Treestar, Inc., San Carlos, CA). cgi/content/full/19/3/451/DC1). PCR products were subjected to
electrophoresis on a 1.8% agarose gel, followed by ethidium bro-
Retroviral Transduction of Stem and Progenitor Cells mide staining. PCR amplification for each experiment was repeated
A full-length murine GATA-1 or FOG-1 cDNA was subcloned into for two or more independently prepared cDNA samples. Relative
the MPSV-based bicistronic retrovirus vector MMP ires-GFP. The gene expression quantification was accomplished by comparing
retrovirus vector was transfected into 293T cells with gag- and pol- the level of any transcript in the target samples to that in control
expression plasmids by CaPO4 coprecipitation. The supernatant cDNA prepared from 2  105 whole bone marrow cells, as reported
from transfected cells was collected after 48 hr and immediately previously (Akashi et al., 2000). PCR cycles for each target gene
stored at –80C until use. FACS-purified HSCs were prestimulated in were at a point when the reaction was in the exponential phase to
Iscove’s Modified Dulbecco’s Medium (IMDM; Invitrogen, Carlsbad, obtain a linear correlation between pixel density units of the PCR
CA) containing 20% FBS in the presence of murine (m) Slf (20 ng/ product and the amount of control cDNA (Akashi et al., 2000).
ml), mLIF (10 ng/ml), mIL-6 (20 ng/ml), and human (h) soluble IL-6
receptor (200 ng/ml) for 18 hr. Cells were subsequently plated onto
recombinant fibronectin fragment-coated culture dishes (RetroNec- Acknowledgments
tin dish; Takara, Tokyo, Japan) with 1 ml of virus supernatant con-
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